Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patie...

by Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-11-01

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.

by Nadia Galizzi, Laura Galli, Andrea Poli, Nicola Gianotti, Elisabetta Carini, Alba Bigoloni, Giuseppe Tambussi, Silvia Nozza, Adriano Lazzarin, Antonella Castagna, Daniela Mancusi, Roberta Termini
Published 2018-01-01

Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study

by Anna Maria Peri, Davide Paolo Bernasconi, Nadia Galizzi, Alberto Matteelli, Luigi Codecasa, Vincenza Giorgio, Antonio Di Biagio, Fabio Franzetti, Antonella Cingolani, Andrea Gori, Giuseppe Lapadula
Published 2018-12-01

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.

by Nicola Gianotti, Andrea Poli, Laura Galli, Michela Franzin, Patrizia Tadini, Nadia Galizzi, Alessia Carbone, Marco Merli, Camilla Muccini, Chiara Oltolini, Andrea Andolina, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Published 2017-01-01

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

by Antonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, Laura Galli, Valentina Mazzotta, Gian Maria Baldin, Stefan Hohaus, Alessandra Bandera, Lucia Alba, Nadia Galizzi, Antonella Castagna, Antonella D'arminio Monforte, Andrea Antinori, ICONA Foundation Study group
Published 2017-01-01